Company
Kodiak Sciences Inc. (KOD)
Standardized SEC financial data for Kodiak Sciences Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001468748 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-146.1%
Free cash flow
-$136.5M
Current ratio
4.72×
EPS (diluted)
$-4.32
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $107.4M | $217.3M | $267.6M | $206.3M | $126.1M | $182.4M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $944.4M | $731.5M | $190.4M | $285.5M | $168.1M | $209.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$83.4M | -$182.3M | -$206.5M | -$154.2M | -$117.3M | -$136.0M |
| Capital expenditures |
Get KOD data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/KOD/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/KOD/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"